Member Info for mulledwine

Lenovo launches 3D all-in-one PC with DDD's TriDef®3D technology Los Angeles, California: DDD Group plc (AIM: DDD), the 3D solutions company, has licensed its TriDef®3D software to Lenovo for its 3D IdeaCentre all-in-one (AIO) PCs which launch today. DDD's TriDef 3D automatically converts DVD movies, video and photo files from 2D to 3D. It also allows over 540 of the latest 2D PC games to be played in 3D, and is available in 37 languages. The TriDef 3D software will be supplied with the AIO PC to deliver 3D viewing using simple, lightweight polarized glasses, making it both cost-effective and convenient. The new B520e 3D AIO PCs deliver a truly immersive 3D visual experience for entertainment and gaming. Lenovo successfully used TriDef 3D last year with the Y560d 3D notebook and is committed to developing more 3D products with TriDef 3D. The 2D-to-3D game conversion solution is compatible with games that run on the DirectX 9, 10 and 11 application programming interfaces. To ensure plenty of content for 3D viewing, Lenovo also includes a selection of original, high definition 3D programming available from Yabazam.com, DDD's 3D entertainment portal. DDD will receive quarterly royalty revenues from Lenovo based on the volume of 3D PCs shipped.

http://www.investegate.co.uk/Article.aspx?id=201111250700207441S

John Allwood, non-executive director of mobile phones seller Carphone Warehouse has rounded up his holding in the company to 10,000 shares. Allwood bought 6,500 shares at 303.9p each, at a cost of just under £20,000, as the shares hit a new 52-week low on Thursday. The company's share price has been hit this month by the decision to close its 'big-box' Best Buy stores in the UK and sell off its interest in Best Buy Mobile in the US.

John Duffy, Chief Executive commented: "The Group has continued to grow and improve despite this most difficult of trading environments, which is encouraging. We continue to innovate and adapt our quality product ranges so that they remain affordable for shoppers and consequently, their popularity has proved enduring. Whilst a difficult balancing act, the management and staff continue to improve and optimise the Group's resilient performance despite these headwinds."

Trading Update Finsbury Food Group plc (AIM: FIF), a leading manufacturer of cake, bread and morning goods, is today holding its Annual General Meeting. At the meeting the Chairman will issue the following update on trading. In the first four months of the new financial year, total Group sales revenues continued to grow strongly to £68.3m. This represents organic growth of just over £10m, an increase of 17% versus prior year. The UK Cake, Bread and Free From businesses all grew strongly delivering just over half the total Group growth whilst Lightbody Europe (LBE), the Group's 50% owned joint venture export business, provided the balance. Year on year growth rates are expected to moderate, once we reach the anniversary of last year's new product launches and increased promotional activity levels. The operating environment remains particularly challenging. Shopper behaviour continues to be affected by the economic uncertainty, and we have experienced ingredient and input cost inflation year on year. Higher sales, resulting from volume growth and price increases, assisted by further internal efficiency initiatives, have partially offset this cost inflation, although operating margins are lower year on year.

http://www.investegate.co.uk/Article.aspx?id=201111240700216759S

Nomura initiates buy on Lancashire Holdings, target price 794p.

Robin Broadhurst, Chairman of Grainger plc, commented: "Our business has continued to demonstrate resilient performance and a proven ability to take advantage of opportunities that will provide long term value. This is supported both by our recent refinancing and by the strong cash generative capability of our portfolio. As a result, whilst being mindful of the challenges presented by the external environment, we are confident the residential market will provide good medium term opportunities. "We have invested wisely in strategic acquisitions during the year. Going forward we will also continue to supplement profits from our core reversionary business with a growth in fee income from our asset and property management activities. Such activities enhance our return on capital and rely less on investment. We therefore anticipate a further reduction in our requirement for debt in the near to medium term and our successful refinancing strategy has been based around this approach. "We look forward to continuing using our skills to enhance our performance within the residential sector."

Financial highlights · Profit before tax £26.1m (2010: loss of £20.8m) · Operating profit before valuation movements and non-recurring items up 34% to £126.2m (30 September 2010: £94.2m) · Gross net asset value per share up 8.2% to 216p (30 September 2010: 200p) · HI Tricomm and Grainger GenInvest acquisitions performing above expectations · £1.2bn of new debt secured during the year and up to the date of this announcement to refinance existing debt and in connection with acquisitions, taking average maturity of the Group's drawn debt to 5.9 years (2010: 3.6 years) · Over £100m of net debt reduction in the second half of the year · Final dividend of 1.30p per share. At the half year £2.2m was returned to shareholders (equivalent to 0.53p per share) through a tender offer for shares making a total return to shareholders equivalent to 1.83p per share (2010: 1.70p) an increase of 8.3% on the final dividend and 7.6% on the full year dividend

http://www.investegate.co.uk/Article.aspx?id=201111240700246779S

Hikma Pharmaceutical (HIK) kept its "buy" rating from Shore Capital, as it continues to increase its Middle East and North Africa oncology portfolio, as well as signing a commercialisation and licensing agreement for Canadian oncology specialist Aeterna Zentaris' anticancer drug Perifosine. The broker notes that the treatment is under review in the US and Europe, with reports due next year. Furthermore, Shore expects the groups branded sales to increase by 7% this year, with stronger growth in 2012. Shares in Hikma edged down 3p to 596p.

Evolution Securities reiterated its "buy" recommendation for GKN (GKN), with a target price of 310p. The engineering group has seen no material change in trading conditions since 19th October, but the broker notes that the shares have fallen by around 15% since then. Evolution attributes this to the market assuming a slump in global car production similar to 2009, while the industry expects demand to grow by 5%. Additionally, accelerated growth in aerospace leads the broker to believe that the shares are materially undervalued. The shares grew 2.6p to 168.9p.

Medusa Mining (MML) retained its "buy" rating from Seymour Pierce, with a 526p target price. The broker expects the gold miner to produce between 90,000 and 100,000 ounces in the 2012 financial year at its Co-O mine, climbing to 120,000 ounces in 2013 and 200,000 in 2014. Additionally, Seymour notes that the company is saving up cash to develop the Bananghilig deposit in the Philippines, with the aim of making it the firm's second 200,000 ounce per year project. The group is also planning to spend at least 22 million dollars (14.2 million pounds) on gold exploration in its 820 square kilometer licence block. Medusa shares slithered up 2p to 332p

Panmure Gordon has downgraded CVS (CVSG) from "buy" to "hold", with a 110p target price. The broker expects the veterinary group to report robust like-for-like sales in its December trading update, benefiting from a steady animal population and surgical advances, but believes the shares have reached a peak, following the recent surge. Additionally, Panmure notes that the company's margins are under pressure due to the poor economic environment. The shares gained 1.5p to 112.5p.

Investec initiates hold on Laird, target price 135p.

Nomura initiates buy on Hiscox, target price 393p

Galvan Research has given packaging company Rexam a buy rating, saying that the FTSE 100 firm is a “canny investment”. Galvan says that a combination of factors - including an upbeat 2012 outlook, a decent charting picture and the possibility that the underperforming Personal Care division could be divested – mark the shares out as a buy.

Peel Hunt has upgraded FTSE 100 industrial engineer Weir from hold to buy following yesterday’s acquisition of Seaboard Holdings. Weir, which operates in the oil, gas, power and mineral markets, announced that it would pay $675m for US wellhead specialist Seaboard, a deal which Peel Hunt thinks looks “highly complementary” to products in Weir’s oil and gas division. “Even though the valuation looks full, it comes with good growth and cross-selling potential”, the broker said. The rating upgrade comes as the shares have de-rated, but as the broker values the company at a 20% premium to the sector average, the target price is reduced from 2,100p to 2,000p.

Just noticed the decimal points are somewhat out of order in last header !

http://sharecrazy.com/beta/Tips/6213/hambledon-mining-speculative-buy-at-3625p-with-an-114p-target-price